Based on limited published evidence, ARMH4 is a membrane-associated protein with potential roles in immune modulation and cell signaling. It down-modulates STAT3 signaling through direct interaction with IL6ST, inhibiting STAT3 phosphorylation at Tyr-705 1. ARMH4 may negatively regulate AKT signaling by modulating mTORC2 activity through RICTOR interaction. In podocytes, ARMH4 overexpression reduces inflammatory mediator release (IL-1B and IL-8), while silencing increases their release 2. The protein is downregulated in glomerular pathologies, suggesting a protective role in kidney disease. ARMH4 has also been identified as a transcriptomic biomarker in oral cancer margins 3.